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Abstract  
BACKGROUND: Ovarian strumal carcinoid is a germ cell tumour characterised by a mixture of thyroid tissue and 
carcinoid. Ovarian struma is a very rare occurrence with 0.3-1% incidence of all ovarian tumours and 3% of 
mature teratomas. Primary carcinoid ovarian tumours are still uncommon as a part of mature teratoma or 
mucinous cystadenoma. There are four major variants of a carcinoid tumour: insular, trabecular, strumal and 
mucinous. A strumal carcinoid is an unusual form of ovarian teratoma composed of an intimate admixture of 
thyroid/carcinoid tissues.  
CASE REPORT: This is a case report of a 59-year old woman with a 5-year clinical history of perimenopausal 
uterine bleeding and three explorative curettages. Gynaecological and ultrasound examinations revealed ovarian 
enlargement with a diameter of 50 mm with hypoechoic zones suspected of benign teratoma. The diagnostic test 
such as Ca-125, AFP, free-T4 and TSH was in normal range. A smooth, solid right ovarian 50 an mm-size 
tumour, as well as small amount of fluid in the Douglas pouch, was found during the total abdominal 
hysterectomy, bilateral salpingo-oophorectomy and staging biopsy.  The histopathology revealed teratoma with 
strumal carcinoid tumour IA stage according to AJCC 2010 of the right ovary and negative cytopathology of the 
fluid from the Douglas pouch. On the postoperative 2-year control, the patient was tumour free, and Ca-125, free-
T4 and TSH were in normal range.  
CONCLUSION: We would like to point out those specific diagnostic tools, such as ultrasound and Ca-125 have 
low specificity and sensitivity in detection of this rare ovarian malignancy. 
 
 
 
 
 
Introduction 
 
Ovarian strumal carcinoid belongs to the germ 
cell family of ovarian malignancy, which is an intimate 
admixture of normal thyroid tissue and carcinoid. 
Ovarian struma has a very rare occurrence with 0.3 -
1% incidence of all ovarian tumours and 3% of mature 
teratomas. Primary carcinoid tumours of the ovary are 
uncommon, rarer than struma ovarii and account only 
for 5% of ovarian teratomas. Three - fifths of the 
strumal carcinoids arise in dermoid cysts or mature, 
solid teratomas. They are frequently composed of 
mature cystic teratomas or, less commonly, mucinous 
cystadenomas. Most patients with strumal carcinoid 
have no symptoms of carcinoid syndrome like flushing 
and diarrhoea, but only symptoms of enlarging mass. 
They can also be just incidental findings. According to 
histopathology, there is four major variants of 
carcinoids: insular, trabecular, strumal and mucinous. 
Treatment with a simple oophorectomy or salpingo-
oophorectomy is effective. Ovarian strumal carcinoid 
metastasises occasionally, and such a type of 
neoplasm should be treated as an ovarian tumour with 
low malignancy potential. 
We present a patient with ovarian teratoma 
and strumal carcinoid tumour.  
 
 
Case Report 
 
A 59 - year old postmenopausal woman was 
referred to our hospital without any symptoms at the 
regular gynaecological checkup, which revealed an 
enlarged cystic right adnexal tumour with mixed 
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echogenicity and increased blood flow. In the 
perimenopausal period, she had 3 consecutive 
explorative curettages for excessive bleeding, and the 
histopathological analysis revealed normal, benign 
findings. Her menopause occurred at the age of 54, 
and after that, she never had any vaginal bleeding.  
She was admitted to our gynaecological 
department for accurate diagnosis and adequate 
treatment. Pelvic examinations revealed an enlarged 
right ovary whose dimensions were inappropriate for 
the woman’s age, with a diameter of 43 mm with both 
hypoechoic and hyperechoic zones. There was no 
amount of fluid in the Douglas pouch.  The uterus was 
in AVFL and had a thin endometrial lining with no 
other notable features observed. The risk of ovarian 
malignancy index (ROMI) = 9, i.e. there is a low risk 
for malignancy: cystic structure with < 1/4 solid parts 
(1point) + senium (1 point) + multilocularity (2 points) 
+ opalescent intralocular liquid (2 points) + intralocular 
papillary vegetation of 3 - 5mm thickness (1 point) + 
thickness of the capsule of 3 - 5mm (1 point) + clear 
rugged margin (1 point) [1]. 
 
Figure 1: Ultrasound examination which revealed a cystic structure 
with < 1/4 solid parts, opalescent intralocular liquid, intralocular 
papillary vegetation of 3 – 5 mm thickness, the thickness of the 
capsule of 3 – 5 mm and a clear, rugged margin 
 
The results of urinalysis and blood chemistry 
tests were within normal ranges and Ca125 - 11.4 
U/mL. Routine investigations including serum 
electrolytes and thyroid function test were all within 
normal limits. Serum tumour markers, such as Ca125, 
carcinoembryonic antigen and Alpha-fetoprotein 
(AFP) were within normal limits. According to the 
clinical and imaging information and postmenopausal 
status of the patient, the possibility of a cystic ovarian 
teratoma was considered and, after discussion with 
the patient and her family, exploratory laparotomy was 
planned. 
The patient underwent surgical treatment, 
total abdominal hysterectomy with bilateral salpingo-
oophorectomy, along with omentectomy, peritoneal 
washing and peritoneal sampling biopsy.  During the 
procedure,   a cystic tumour with a diameter of 5 cm - 
size arising from the right ovary with the intact 
capsule, mobile and well circumscribed was 
visualised. The uterus left ovary, and both tubes were 
normal. At the same time, a peritoneal washing was 
performed for cytological examination. The 
postoperative period was uneventful, and the patient 
was discharged on the 7th postoperative day.  
According to the pathology report, the tumour 
of the right ovary measured 6 x 4.5 x 4.5 cm, and it 
was lobulated, with the smooth outer surface. The cut 
surface revealed a cystic formation filled with 
sebaceous material and a tuft of hair. In the wall of the 
cyst, there was solid, homogenous, tan - brown to 
yellow, circumscribed nodule measured 3.5 cm.  
Microscopic examination revealed a cyst lined 
by stratified squamous epithelium with skin 
appendages, together with mature neuronal elements 
and fat tissue (Figure 2A).  The solid nodule was 
composed partly of thyroid tissue with thyroid follicles 
filled with colloid and partly of tumour cell clusters 
composed of monomorphic cells with abundant 
granular cytoplasm.  The nuclear chromatin was finely 
granular and "salt and pepper" in appearance. The 
tumour cells were arranged in trabecular structures, or 
in solid nests and small acini (Figure 2B, and 3).  
A)                                                   B) 
 
Figure 2: A - Mature cystic teratoma: stratified squamous epithelium 
with skin appendages, mature  neuronal elements and  fat tissue, 
H&E x10; B – Hematoxylin-eosin staining of the strumal carcinoid 
tumour; Thyroid tissue (bottom left) and carcinoid tumour (upper 
right), H&E x10 
 
Immunohistochemically, tumour cells were 
diffusely positive for synaptophysin, neuron-specific 
enolase (NSE) and CD56 and focally positive for 
chromogranin A. Mitotic activity of tumour cells was 3 
mitoses/10HPF and proliferative index measured with 
Ki - 67 was 10% (Figure 4).  
 
Figure 3: Trabecular carcinoid tumour composed of solid parts and 
showing a trabecular growth pattern (H&E × 20) (left up). Carcinoid 
cells with oblong nuclei and columnar cytoplasm presented with 
long, wavy, parallel ribbon-like arrangement (H&E × 40) (right up). 
Insular carcinoid tumour composed of solid nests and small acini 
(H&E x 20) (left down); H&E x 40 (right down) 
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This part of the tumor was diagnosed as 
trabecular and insular carcinoid. Because of the 
presence of mature cystic teratoma and thyroid 
components, the definitive diagnosis was mature 
cystic teratoma with strumal carcinoid.  Cytological 
examination of the fluid from the Douglas pouch was 
negative for tumour cells.  
  
  
Figure 4: Immunohistochemically tumor cells were positive for: 
synptophysin, x40 (left up); NSE, x 40 right up); chromogranin A, x 
40 (left down); CD56, x 20 (right down).Figure 4. 
Immunohistochemically tumor cells were positive for: synptophysin, 
x 40 (left up); NSE, x 40 right up); chromogranin A, x 40 (left down); 
CD56, x 20 (right down) 
 
According to UICC and AJCC 7
th
 edition from 
2010, the disease was in IA stage. Given her 
pathological findings, she was referred to an 
oncologist for consultation but will have a good 
prognosis, and she is scheduled to be followed up by 
physical examinations, tumour markers ultrasounds, 
and CT scans. 
 
 
Discussion 
 
Adnexal masses are the most common 
gynaecological findings. Ovarian tumours, as a part of 
adnexal tumour masses, represent two - thirds of 
these cases. Histopathological diagnosis after 
adequate surgical treatment is the golden standard for 
a final diagnosis of an adnexal mass. The primary 
ovarian carcinoid tumours are rare and represent less 
than 0.1% of ovarian malignancies [2].
 
According to the WHO classification, they 
represent a group of ovarian monodermal teratomas 
[3]. Monodermal teratoma is a benign teratoma 
composed either solely or predominantly of only one 
highly specialised tissue type. Those composed 
predominantly of thyroid tissue are termed struma 
ovarii [4]. Most tumours present in peri - or 
postmenopausal women with symptoms of enlarging 
mass or are just incidental findings [5]. They most 
commonly appear as a unilateral mass, but in one - 
fifth of the cases a contralateral tumour can also be 
found. More than a half of ovarian carcinoids are 
found as a part of mature cystic teratoma. Regarding 
the clinical signs and symptoms, some patients 
present with typical signs and symptoms of the 
carcinoid syndrome such as episodic cutaneous 
flushing, abdominal cramps, diarrhoea, carcinoid heart 
disease, etc. mediated by bioactive substances that 
carcinoid tumour cells produce [2]. Carcinoid tumours 
secrete a wide variety of neurohumoral substances 
such as serotonin, histamine, tachykinin, bradykinin, 
kallikrein, corticotrophin, substance P, motilin, and 
prostaglandins [6].
 
The above - mentioned 
complications are almost solely due to the secretion of 
serotonin. In our case, the patient had no symptoms 
of carcinoid syndrome, nor symptoms due to the 
enlarging mass. 
Primary ovarian carcinoids are histologically 
divided into four major types: insular, trabecular, 
strumal and mucinous. A mixed type has also been 
reported, which is composed of any combination of 
the pure types. Primary ovarian carcinoids also arise 
in association with mature cystic teratomas or 
mucinous tumours and present various findings on 
preoperative images. Therefore, the preoperative 
diagnosis of these tumours may be difficult [7]. Islands 
of uniform neoplastic cells are typical for insular 
carcinoids. About 30% of these tumours are 
associated with the carcinoid syndrome. Trabecular 
carcinoids are characterised by the growth of tumour 
cells in trabeculae and only rarely present with 
endocrine manifestations [2]. Mucinous carcinoid 
tumours of the ovary are pure tumours, and rarely 
represent part of the strumal carcinoid. It is 
considered that primary mucinous carcinoid tumour of 
the ovary represents a specific histopathologic entity. 
Unlike other types of primary ovarian carcinoid 
tumours, it behaves like an aggressive malignant 
neoplasm [8]. Nevertheless, multiple metastases with 
a higher mitotic rate and focal necrosis have been 
reported. The presence of mitoses or necroses in a 
tumour is useful for predicting poor prognosis. 
Differential diagnoses of primary ovarian 
carcinoid include metastatic carcinoid, granulosa cell 
tumours, poorly differentiated primary or metastatic 
adenocarcinoma, Brenner tumours and 
androblastoma [2] [13]. Approximately 5% of primary 
carcinoid tumours of the non-mucinous type have a 
malignant clinical course, but so far there are no 
histological parameters that can predict malignancy 
[2] [9]. Insular carcinoids are among the tumours with 
low malignant potential. Cases of strumal carcinoid 
metastases which consist of both the carcinoid and 
thyroidal type are rarely reported [9].
 
Mucinous 
carcinoids tend to be more aggressive in the clinical 
course.  
Premenopausal women with tumours 
confined to the ovary may be treated with fertility-
sparing surgery, as tumors are usually unilateral and 
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carry a good prognosis, but careful staging to exclude 
occult metastases is important. However, in the 
absence of controlled trials to validate this approach, 
hysterectomy with bilateral salpingo - oophrectomy 
and surgical debulking of extra-ovarian spread and/or 
metastases is the treatment of choice [10] [11]. In rare 
patients with a mucinous variant of the ovarian 
carcinoid, omentectomy and para - aortic lymph node 
dissection may also be needed because these tumors 
spread mainly through lymphatics [10] [12]. 
However, because of the difficulty of setting 
an accurate preoperative diagnosis, most cases have 
been diagnosed based on postoperative pathology 
findings.  
With this case report the correlation between 
the preoperative clinical assessment and 
intraoperative assessment and the histopathological 
diagnosis can be made. 
We would like to point out that specific 
diagnostic tools, as well as serological tests for 
ovarian malignancy, have low specificity and 
sensitivity in detection of this rare ovarian malignancy 
with no clinical symptoms. 
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